Susquehanna International Group’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-18,700
Closed -$193K 12901
2023
Q3
$193K Buy
+18,700
New +$217K ﹤0.01% 10270
2023
Q2
Sell
-171,900
Closed -$1.92M 12700
2023
Q1
$1.92M Buy
171,900
+158,500
+1,183% +$1.56M ﹤0.01% 5231
2022
Q4
$113K Buy
13,400
+800
+6% +$7.61K ﹤0.01% 10838
2022
Q3
$210K Buy
+12,600
New +$232K ﹤0.01% 10717
2022
Q2
Sell
-30,200
Closed -$749K 13511
2022
Q1
$749K Buy
+30,200
New +$780K ﹤0.01% 7895
2021
Q4
Sell
-22,300
Closed -$802K 13562
2021
Q3
$802K Buy
+22,300
New +$877K ﹤0.01% 8131
2021
Q2
Sell
-5,100
Closed -$233K 12968
2021
Q1
$233K Buy
+5,100
New +$293K ﹤0.01% 11120

Other funds holding LUNG

Susquehanna International Group's LUNG Position: Q1 2026 in Review

Susquehanna International Group reduced its Pulmonx (LUNG) stake by 53% in Q1 2026, selling an estimated $166K and leaving 89,069 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #12240.

Susquehanna International Group first reported a position in LUNG in Q1 2022 and has held it in 17 quarters since. The position peaked at $4.51M in Q1 2022. 114 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • Susquehanna International Group held 89,069 shares of Pulmonx worth $115K as of Q1 2026.
  • Susquehanna International Group sold 100,371 Pulmonx shares in Q1 2026, an estimated $166K.
  • Pulmonx made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12240 holding.
  • Susquehanna International Group first reported a position in Pulmonx in Q1 2022 and has held it in 17 quarters since.
  • Susquehanna International Group's Pulmonx position peaked at $4.51M in Q1 2022.
  • 114 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.